EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share
EQHA.WS
EQHA.WS was delisted on the 25th of November, 2022.
61 hedge funds and large institutions have $5.61M invested in EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share in 2022 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 3 closing their positions.
133% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 3
7% more funds holding
Funds holding: 57 → 61 (+4)
20% less capital invested
Capital invested by funds: $7.05M → $5.61M (-$1.43M)
40% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MC
Meteora Capital
Boca Raton,
Florida
|
+$57K |
| 2 |
RA
Ramius Advisors
New York
|
+$22.5K |
| 3 |
CS
Clear Street
New York
|
+$12.6K |
| 4 |
AGM
Alpine Global Management
New York
|
+$11K |
| 5 |
EFI
EHP Funds Inc
Toronto,
Canada
|
+$10.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PI
PEAK6 Investments
Chicago,
Illinois
|
-$70K |
| 2 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$10.5K |
| 3 |
GCL
Glazer Capital LLC
New York
|
-$7K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$1.55K |
| 5 |
QGA
Q Global Advisors
Fort Worth,
Texas
|
-$476 |
EQHA.WS Hedge Fund Activity: Q2 2022 in Review
61 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share (EQHA.WS) for Q2 2022, worth a combined $5.61M — down 20% from $7.05M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new EQHA.WS positions and 3 closed out — a net gain of 4 holders — while 3 added to existing stakes and 5 trimmed.
The largest buyer was Meteora Capital, opening a new position worth an estimated $57K. The largest seller was PEAK6 Investments, exiting entirely with an estimated $70K sold.
- 61 institutional investors held EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share (EQHA.WS) as of Q2 2022, up from 57 in Q1 2022.
- Funds reported $5.61M of EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share stock for Q2 2022, down 20% quarter-over-quarter.
- 7 funds opened new EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share positions in Q2 2022 and 3 closed out, a net change of +4 holders.
- The largest EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share buyer in Q2 2022 was Meteora Capital, an estimated $57K added.
- The largest EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share seller in Q2 2022 was PEAK6 Investments, an estimated $70K sold.
Based on aggregated 13F filings for Q2 2022.